Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Gains from Investment Securities: 2013-2024

Historic Gains from Investment Securities for Armata Pharmaceuticals (ARMP) over the last 11 years, with Dec 2024 value amounting to $10.8 million.

  • Armata Pharmaceuticals' Gains from Investment Securities was N/A to $337,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $656,000, marking a year-over-year change of. This contributed to the annual value of $10.8 million for FY2024, which is 298.44% up from last year.
  • As of FY2024, Armata Pharmaceuticals' Gains from Investment Securities stood at $10.8 million, which was up 298.44% from $2.7 million recorded in FY2023.
  • In the past 5 years, Armata Pharmaceuticals' Gains from Investment Securities registered a high of $26.1 million during FY2021, and its lowest value of $628,000 during FY2020.
  • Moreover, its 3-year median value for Gains from Investment Securities was $8.7 million (2022), whereas its average is $7.4 million.
  • In the last 5 years, Armata Pharmaceuticals' Gains from Investment Securities soared by 4,049.04% in 2021 and then slumped by 68.85% in 2023.
  • Yearly analysis of 5 years shows Armata Pharmaceuticals' Gains from Investment Securities stood at $628,000 in 2020, then soared by 4,049.04% to $26.1 million in 2021, then tumbled by 66.73% to $8.7 million in 2022, then plummeted by 68.85% to $2.7 million in 2023, then spiked by 298.44% to $10.8 million in 2024.